You are viewing: US Endoscope Reprocessing Market analysis
Part of: Endoscope Reprocessing Market (Global)

The US Endoscope Reprocessing Market was valued at $284.7 Million in 2025 and projected to reach to $420.9 Million by 2030, representing a compound annual growth rate of 8.1%. The US endoscope reprocessing market is poised for steady expansion through 2030, driven by aging demographics increasing endoscopic procedure demand and healthcare facilities' commitment to infection prevention.

US Endoscope Reprocessing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Endoscope Reprocessing Market Trends and Insights

  • The US market is driven by stringent infection control regulations, increasing endoscopic procedure volumes, and rising healthcare facility investments in automated reprocessing systems.
  • The US healthcare sector's emphasis on patient safety and compliance with FDA and CDC guidelines continues to propel demand for advanced endoscope reprocessing solutions. In the US, the market benefits from a mature healthcare infrastructure and high adoption rates of technologically advanced reprocessing equipment.
  • The US endoscope reprocessing sector is characterized by significant investments in high-level disinfection (HLD) and sterilization technologies.
  • Between 2025 and 2030, the US market will experience accelerated growth driven by expanding surgical centers, rising awareness of healthcare-associated infections (HAIs), and the integration of digital tracking systems in reprocessing workflows..

Key Market Statistics

  • CAGR (2025-2030) 8.1% CAGR
  • Market Size, 2025 ~USD 284.7 Million
  • Forecast, 2030 ~USD 420.9 Million
  • Country US

US Endoscope Reprocessing Market Overview

Market Valuation :

The US endoscope reprocessing market is valued at $284.7 million in 2025 and is projected to reach $420.9 million by 2030, representing significant growth in the healthcare infrastructure sector.

Regulatory Compliance Drivers :

Stringent infection control regulations from the FDA and CDC are compelling US healthcare facilities to adopt advanced endoscope reprocessing systems, ensuring patient safety and procedural standards.

Procedure Volume Growth :

Increasing endoscopic procedure volumes across US hospitals and ambulatory surgical centers are driving demand for efficient and automated reprocessing solutions to handle higher throughput.

Automation Investment Trend :

US healthcare facilities are increasingly investing in automated reprocessing systems to reduce manual labor, improve consistency, and enhance operational efficiency in endoscopy departments.

US Endoscope Reprocessing Market Dynamics

  • Hospitals and surgical centers are prioritizing capital investments in automated reprocessing technologies to meet regulatory requirements and improve patient outcomes.
  • The 8.1% CAGR reflects strong market fundamentals supported by continuous procedural growth and technological advancement.
  • Key drivers include enhanced FDA guidelines, rising awareness of healthcare-associated infections, and the shift toward value-based care models that emphasize quality and safety metrics in endoscopy departments..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US endoscope reprocessing market is valued at $284.7 million in 2025 and will reach $420.9 million by 2030.
    • The US market is growing at an 8.1% CAGR, driven by regulatory compliance and infection control priorities.
    • The US healthcare system's focus on HAI prevention and FDA/CDC adherence accelerates adoption of automated reprocessing systems.
    • The US market expansion is supported by increasing endoscopic procedure volumes and investments in surgical center infrastructure.

    Endoscope Reprocessing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment FLEXIBLE ENDOSCOPES (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 9.4% from 2025 to 2030
    Largest Segment HOSPITALS & ASCS (End User)
    Market Size Base Year (Billions) ~USD 2.71 (2025)
    Revenue Forecast (Billions) ~USD 4.24 (2030)
    Segments Covered Product, Type, Portability, Type Of Endoscope, End User

    US Endoscope Reprocessing Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product

    • Endoscope Reprocessing Consumables
    • Endoscope Reprocessing Equipment
    • Endoscope Tracking Solutions

    By Type

    • Automated Endoscope Reprocessors (Aer)
    • Detergents & Wipes
    • Double-Basin Automated Endoscope Reprocessors
    • Endoscope Drying, Storage, & Transport Systems
    • Endoscope Drying, Storage, And Transport Systems
    • High-Level Disinfectants & Test Strips
    • High-Level Disinfectants And Test Strips
    • Other Products
    • Single-Basin Automated Endoscope Reprocessors

    By Portability

    • Portable Aers
    • Portable Automated Endoscope Reprocessors
    • Standalone Aers
    • Standalone Automated Endoscope Reprocessors

    By Type Of Endoscope

    • Flexible Endoscopes
    • Rigid Endoscopes

    By End User

    • Hospitals & Ascs
    • Other End Users
    • Specialty Clinics

    US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOSPITALS & ASCS784.4849.8922.11002.210911189.51299.114219
    OTHER END USERS64.568.67377.983.389.195.5102.67
    SPECIALTY CLINICS127.7136.9146.9158170.2183.7198.5214.97.9
    TOTAL976.61055.21142.11238.11344.41462.31593.11738.58.8

    Target Audience

    • Medical Device Manufacturers : Need US market data to develop and commercialize endoscope reprocessing equipment, understand regulatory pathways, and identify growth opportunities in hospital and ASC segments.
    • Healthcare Facility Administrators : Require market insights to justify capital investments in automated reprocessing systems, benchmark against peer facilities, and optimize endoscopy department operations and compliance.
    • Reprocessing Service Providers : Need detailed US market analysis to expand service offerings, identify underserved regions, and develop business cases for outsourced reprocessing solutions to healthcare facilities.
    • Healthcare Consultants & Advisors : Use US-specific market data to advise hospital systems on technology investments, operational efficiency improvements, and infection prevention strategies in endoscopy departments.
    • Private Equity & Investors : Require validated US market sizing and growth forecasts to evaluate investment opportunities in endoscope reprocessing companies and assess portfolio company performance potential.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Confirm the US market opportunity with precise valuation data ($284.7M in 2025) and validated 8.1% CAGR projections through 2030, enabling accurate business planning and investment decisions.
    • Regulatory Landscape Intelligence : Understand FDA and CDC compliance requirements driving US market adoption, helping manufacturers and service providers align product development with stringent infection control standards.
    • Competitive Positioning Strategy : Identify market dynamics specific to US healthcare facilities, including automation adoption rates and capital expenditure trends, to benchmark competitive positioning and market entry strategies.
    • Demand Forecasting Accuracy : Leverage detailed US-specific growth projections to forecast demand for reprocessing equipment, services, and consumables, supporting supply chain planning and revenue modeling.
    • Investment & Partnership Opportunities : Identify high-growth segments within the US market and facility types most likely to invest in advanced reprocessing solutions, guiding M&A and partnership development strategies.

    Frequently asked questions

    What is the current size of the US endoscope reprocessing market?

    The US endoscope reprocessing market is valued at $284.7 million in 2025.

    What is the projected size of the US endoscope reprocessing market by 2030?

    The US endoscope reprocessing market is projected to reach $420.9 million by 2030.

    What is the growth rate of the US endoscope reprocessing market?

    The US endoscope reprocessing market is growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2030.

    What are the main drivers of growth in the US endoscope reprocessing market?

    The US market is driven by stringent FDA and CDC regulations, increasing endoscopic procedure volumes, rising healthcare-associated infection awareness, and investments in automated reprocessing technologies.

    Which factors are influencing endoscope reprocessing adoption in the US?

    The US adoption is influenced by patient safety priorities, compliance requirements, expansion of surgical centers, digital tracking integration, and healthcare facility modernization efforts.

    RESEARCH METHODOLOGY

    The study involved key activities in estimating the current market size for the endoscope reprocessing market. Extensive secondary research was conducted to gather information on this sector. The next step was to validate these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up methods, were used to calculate the total market size. Subsequently, market segmentation and data triangulation techniques were applied to estimate the size of various segments and subsegments within the endoscope reprocessing market.

    The four steps involved in estimating the market size are:

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global endoscope reprocessing market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    During the primary research process for the endoscope reprocessing market, various stakeholders from both supply and demand sides were interviewed to gather qualitative and quantitative insights. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, product development managers, and heads of technology and innovation from leading companies offering endoscope reprocessing equipment, consumables, and tracking systems. On the demand side, respondents included infection control specialists, hospital procurement officers, sterilization technicians, and representatives from ambulatory surgical centers (ASCs), specialty clinics, and hospitals. The primary research aimed to validate the segmentation framework, identify key players and their strategies, and understand current and emerging trends, challenges, and market dynamics impacting the endoscope reprocessing industry.

    The following is a breakdown of the primary respondents:

    Endoscope Reprocessing Market

    Note 1: Other designations include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were determined based on revenue mapping of leading product manufacturers and OEMs active in the worldwide endoscope reprocessing market. All key service providers were identified at the global, national, and/or national/regional levels. Revenue mapping for the respective business segments and sub-segments was conducted for the major players. The global endoscope reprocessing market was split into various segments and subsegments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of endoscope reprocessing providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from endoscope reprocessing (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global endoscope reprocessing market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    The research methodology used to estimate the market size includes the following:

    Endoscope Reprocessing Market

    Data Triangulation

    After determining the overall market size using the process outlined above, the total market was divided into several segments. To complete the market engineering process and obtain precise data for all segments and subsegments, data triangulation and market breakdown methods were used wherever applicable. The data was triangulated by examining various factors and trends from both the demand and supply sides.

    Market Definition

    Endoscope reprocessing involves cleaning, high-level disinfection, or sterilization of reusable endoscopes to ensure safe reuse and prevent cross-contamination. The market includes automated reprocessing equipment (such as automated endoscope reprocessors (AER) and endoscope drying, storage, and transport systems), consumables (such as detergents, wipes, and disinfectants), and tracking systems that help maintain compliance with infection control standards. These solutions are essential for reducing healthcare-associated infections (HAIs) and are commonly used across hospitals, ambulatory surgical centers, and specialty settings clinics.

    Stakeholders

    • Endoscope Reprocessing Equipment and Consumables Manufacturers
    • Hospitals and Ambulatory Surgical Centers (ASCs)
    • Endoscopy Units and Clinics
    • Distributors and Suppliers of Endoscope Reprocessing Solutions
    • Contract Manufacturers of Endoscope Reprocessing Devices
    • Research & Consulting Firms Focused on Infection Control and Reprocessing
    • Regulatory Bodies and Government Health Organizations
    • Venture Capitalists and Investors
    • Government Organizations

    Report Objectives

    • To define, describe, segment, and forecast the endoscope reprocessing market by product, type of endoscope, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscope reprocessing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

    Get the Full Endoscope Reprocessing Market Report

    Full forecast, segment splits, and company analysis for all Endoscope Reprocessing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status